SPL 2.22% 9.2¢ starpharma holdings limited

Ann: Positive DEP Cabazitaxel Phase 2 Results in Multiple Cancer, page-29

  1. 15,531 Posts.
    lightbulb Created with Sketch. 5602
    let’s see if they can turn this into a big Pharma dollar deal.


    LMAO .... JF & Co. haven't been able to for the last 2 years regardless of the claims of being in 'confidential commercial negotiations with several potential pharmaceutical companies' so I wouldn't hold my breath


    I also don't see big pharma wanting to shell out millions of dollars for a single DEP® Cabazitaxel license deal when they could probably takeover the entire company for under $1 now
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.2¢
Change
0.002(2.22%)
Mkt cap ! $37.93M
Open High Low Value Volume
9.2¢ 9.3¢ 9.2¢ $3.349K 36.18K

Buyers (Bids)

No. Vol. Price($)
2 113072 9.2¢
 

Sellers (Offers)

Price($) Vol. No.
9.3¢ 108436 2
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.